Clinical Trials Sponsored by RLS Global

Total 1310 results

RLS Global

Terminated

Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement

Pressure Ulcer

Sweden, United Kingdom, Aland Islands
RLS Global

Terminated

A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv® (ChloraSolv02)

Chronic Diabetic Foot Ulcer | Chronic Leg Ulcer

Sweden
RLS Global

Completed

An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

Chronic Ulcer at Lower Leg

Sweden
SLS France
Global D

Recruiting

To Evaluate the Performance and Safety of Personalized Implants in CMF Surgery Indicated for Orthognathic Surgery

Surgery | Maxilla Fracture

Belgium, France
Global D

Recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Trauma Surgery (CMF-TRAUMA)

Trauma Injury | Maxillofacial Trauma | Maxilla Fracture

France
Global BioClinical

Withdrawn

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples (GBCPRT0008)

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Hematologic Cancer

United States
Global Biotech

Completed

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Cerebrovascular Accident

Taiwan
Global BioClinical

Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples (GBCPRT0009)

Cancer

United States
Global D

Recruiting

Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems

Dental Implants

France, Greece
Global D

Active, not recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery (CMF-ORTHO)

Maxillofacial Abnormalities | Orthognathic Surgery | Maxilla Fracture

France
NLS Pharmaceutics

Completed

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Narcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy

United States
NLS Pharmaceutics

Completed

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Narcolepsy | Excessive Daytime Sleepiness | Cataplexy Narcolepsy

United States
Cohen Global, Ltd.

Not yet recruiting

Subcutaneous Administration of MD-18 in Healthy Subjects

Healthy Volunteers
Global Neurosciences Institute

Recruiting

Verapamil for Neuroprotection in Stroke

Ischemic Stroke

United States
Global Cell Med

Unknown

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Diabetes Complications | Diabetes Mellitus Progression

Bahamas
NLS Pharmaceutics

Not yet recruiting

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 (AMAZE)

Narcolepsy Type 1 | Narcolepsy With Cataplexy
NLS Pharmaceutics

Completed

Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States
Global Kinetics Corporation

Recruiting

Personal KinetiGraph® Clinical Validation Study

Parkinson Disease | Movement Disorders

United States
Global Neurosciences Institute

Recruiting

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
ProgenaCare Global, LLC

Active, not recruiting

Efficacy of ProgenaMatrix™ in the Management of DFUs

Diabetic Foot Ulcer

United States
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Global Surgery Amsterdam

Completed

From Short-term Surgical Missions Towards Sustainable Partnerships

Global Surgery | Medical Missions

Netherlands
Global Blood Therapeutics

Terminated

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

Idiopathic Pulmonary Fibrosis | Hypoxemia

United Kingdom, United States
Global Blood Therapeutics

Completed

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Renal Impairment

United States
Global Blood Therapeutics

Completed

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Sickle Cell Disease

United States
Global Blood Therapeutics

Completed

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Anemia, Sickle Cell

United States
Global Aesthetics LLC

Not yet recruiting

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Wrinkle

United States
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
Global Kinetics Corporation

Active, not recruiting

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

Parkinson Disease

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
Global Blood Therapeutics

Completed

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Idiopathic Pulmonary Fibrosis | Hypoxemia

United States
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Aspen Global Incorporated

Completed

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Injection Site Reaction
Global Blood Therapeutics

Completed

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Sickle Cell Disease

United Kingdom
Global Blood Therapeutics

Completed

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

Sickle Cell Disease | Healthy Subjects

United Kingdom
Global Blood Therapeutics

Completed

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

Sickle Cell Disease

United States
MedLogic Global Limited

Completed

Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions

Laparoscopic Surgery

United Kingdom
HAE Global Registry Foundation

Recruiting

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II (HGR)

Hereditary Angioedema Type I and II

Italy
Global United Pharmaceutical Corporation

Not yet recruiting

Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults (CREWS01)

Asthma

United States
PepsiCo Global R&D

Completed

Utility of Transdermal Optical Imaging (TOI) as a Non-invasive Measure of Hydration Status: Phase 3a for Model Development

Dehydration

United States
PepsiCo Global R&D

Completed

Influence of Coffeeberry Ingestion on Soccer Skill Performance

Skill Performance | Soccer Performance | Coffeeberry Effects

United Kingdom
PepsiCo Global R&D

Completed

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

Pharmacokinetics

United States
PepsiCo Global R&D

Completed

Liking Adaptation to Beverages of Varying Sweetness Levels Following Prolonged Exposure

Sweetness Liking Adaptation

Mexico
PepsiCo Global R&D

Completed

Sleep, Physical Activity, and Dietary Habits Among High School Student-athletes and Non-athletes During an Academic Semester

Sleep Quantity | Sleep Efficiency

United States
PepsiCo Global R&D

Completed

Avenanthramides and Exercise

Avenanthramides
PepsiCo Global R&D

Completed

Effect of Phytochemicals on Aspects of Cognitive Performance

Cognitive Performance

United States
PepsiCo Global R&D

Completed

Assess Extent of Agreement Between Online 24-hr Dietary Recall and Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive 2 Days 1 wk Apart to Adults and School Age Children

Dietary Habits

Russian Federation
PepsiCo Global R&D

Completed

Effects of Hydrolyzed Collagen and Vitamin C on Explosive Performance

Collagen Synthesis | Rate of Force (RFD) Development

United States
PepsiCo Global R&D

Completed

Effects of Beverages Containing Orange or Apple Pomace on Digestive Health in Adults

Digestive Health

United States

3

Subscribe